Surgery – Means for introducing or removing material from body for... – Infrared – visible light – ultraviolet – x-ray or electrical...
Reexamination Certificate
2006-04-18
2006-04-18
Bockelman, Mark (Department: 3762)
Surgery
Means for introducing or removing material from body for...
Infrared, visible light, ultraviolet, x-ray or electrical...
Reexamination Certificate
active
07031768
ABSTRACT:
A planar disposable transdermal iontophoretic delivery system is disclosed which includes amounts of an oxidizable species and a reducible species connected by a common conductor forming a galvanic battery for serving as the sole source of power and control for the system, an amount of a therapeutic agent is provided to be driven through the skin of a patient solely through the use of the galvanic battery. The galvanic battery is provided with a lot-tested coulombic capacity rating to predict dosage.
REFERENCES:
patent: 116562 (1871-07-01), Collins
patent: 175974 (1876-04-01), Hall
patent: 222276 (1879-12-01), Hunter
patent: 385556 (1888-07-01), Hoke
patent: 393741 (1888-12-01), Collins
patent: 770014 (1904-09-01), Linn
patent: 857664 (1907-06-01), Overman
patent: 1967927 (1934-07-01), Deutsch
patent: 4619252 (1986-10-01), Ibbott
patent: 4713050 (1987-12-01), Sibalis
patent: 4722726 (1988-02-01), Sanderson et al.
patent: 4747819 (1988-05-01), Phipps et al.
patent: 4752285 (1988-06-01), Petelenz et al.
patent: 4767401 (1988-08-01), Seiderman
patent: 4927408 (1990-05-01), Haak et al.
patent: 4950229 (1990-08-01), Sage, Jr.
patent: 5160315 (1992-11-01), Heinecke et al.
patent: 5162042 (1992-11-01), Gyory et al.
patent: 5203768 (1993-04-01), Haak et al.
patent: 5221254 (1993-06-01), Phipps
patent: 5254081 (1993-10-01), Maurer et al.
patent: 5295979 (1994-03-01), DeLaurentis et al.
patent: 5298017 (1994-03-01), Theeuwes et al.
patent: 5320731 (1994-06-01), Muller et al.
patent: 5322520 (1994-06-01), Milder
patent: 5354321 (1994-10-01), Berger
patent: 5356632 (1994-10-01), Gross et al.
patent: 5358483 (1994-10-01), Sibalis
patent: 5403275 (1995-04-01), Phipps
patent: 5405317 (1995-04-01), Myers et al.
patent: 5431625 (1995-07-01), Fabian et al.
patent: 5436090 (1995-07-01), Kono et al.
patent: 5458569 (1995-10-01), Kirk, III et al.
patent: 5466217 (1995-11-01), Myers et al.
patent: 5533971 (1996-07-01), Phipps
patent: 5605536 (1997-02-01), Sibalis
patent: 5624415 (1997-04-01), Cormier et al.
patent: 5651768 (1997-07-01), Sibalis
patent: 5685837 (1997-11-01), Horstmann
patent: 5759564 (1998-06-01), Milder et al.
patent: 5772688 (1998-06-01), Muroki
patent: 5983130 (1999-11-01), Phipps et al.
patent: 1967927 (1934-07-01), None
patent: 2263792 (1974-03-01), None
patent: 0060451 (1982-03-01), None
patent: 0308572 (1984-08-01), None
patent: 456 122 (1991-05-01), None
patent: 0 893 139 (1998-07-01), None
patent: 2 263 792 (1975-10-01), None
patent: 410009 (1934-05-01), None
patent: 2.206493 (1989-01-01), None
patent: 0456122 (1995-11-01), None
patent: WO 01/49365 (2001-07-01), None
Aiontophoresis: Applications in Transdermal Medication Delivery@, Charles T. Costello, Arthur H. Jeske,Physical Therapy, vol. 75, No. 6, Jun. 1995, pp. 554-563.
Atransdermal Iontophoresis. Part I: Basic Principles and Considerations@, Vinod Nair, Omathanu Pillai, Ramarao Poduri and Ramesh Panchagnula,Methods Find Exp Clin Pharmacol, 1999, 21(2): 139-151.
Anderson Carter R.
Anderson Clayton J.
Morris Russell L.
Sembrowich Walter L.
Birch Point Medical, Inc.
Bockelman Mark
Mersereau C. G.
Nikolai & Mersereau , P.A.
LandOfFree
Controlled dosage drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled dosage drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled dosage drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3620182